2 February 2026

There is plenty of evidence that earlier detection and better‑coordinated care pathways can dramatically improve survival while reducing costs and improving quality of life. Countries with strong policy frameworks detect lung cancer earlier and deliver more equitable, high‑quality care.

National cancer control plans (NCCPs) are often the best drivers of such improvements; they are the backbone of a country’s cancer response. When they prioritise lung cancer and embed strategies for prevention, early detection, diagnosis and care, NCCPs create policy conditions that can save lives.
 

What are NCCPs?

NCCPs are strategic, government‑led policy documents that set out a country’s priorities and the actions required to prevent, detect, treat, monitor and manage cancer. They reflect a country’s cancer rate, health‑system capacity and available resources.

Most NCCPs outline coordinated strategies, including:

  • prevention (e.g., tobacco control, vaccination)
  • early detection and diagnosis
  • treatment (including surgery, radiotherapy and medicines)
  • palliative and supportive care
  • data collection, surveillance and monitoring
  • workforce planning and infrastructure strengthening.

NCCPs are internationally recognised as essential for organising services and allocating resources efficiently. They reduce inequalities and translate global commitments – including World Health Organization (WHO) cancer and non-communicable disease (NCD) targets – into action.
 

How NCCPs strengthen lung cancer care

NCCPs help drive more equitable and person‑centred cancer care by:

Setting clear priorities

They define which cancers require the most attention and identify the actions needed along the care pathway – from prevention to survivorship and palliative care.

Reducing fragmentation

Without a unifying plan, cancer initiatives risk becoming siloed. NCCPs align stakeholders; clarify roles and responsibilities; and create mechanisms for implementing interventions, treatment, monitoring and evaluation.

Translating global commitments into country‑level action

They help governments implement WHO resolutions and NCD commitments while embedding lung cancer priorities that reflect population and health system needs in sustainable strategies.

Improving equity

Well‑designed NCCPs address disparities by identifying underserved populations and planning services that reach them. They also guide financial planning, which is critical given persistent under‑funding in many low‑ and middle‑income countries.

Supporting accountability and better outcomes

Countries with well‑implemented NCCPs achieve stronger performance and higher survival rates. Effective plans are regularly updated ‘living documents’ informed by data and supported by quality assurance and workforce planning.
 

Why NCCPs matter for lung cancer advocacy

Despite lung cancer’s significant toll, many countries lack comprehensive, actionable lung cancer components within their NCCPs – or they fail to fund or implement them fully. Strengthening these plans is an achievable path to:

  • making lung cancer a clear national priority
  • securing sustained investment
  • building the workforce and infrastructure needed for high‑quality care
  • enabling data‑driven decision‑making
  • improving equity and access for underserved communities.

 

Real-world action: global momentum for lung cancer policy

Lung cancer is often seen as too complex, too expensive or too advanced to tackle. But the evidence proves otherwise: people can survive the disease when countries make lung cancer a policy priority and implement strong early-detection strategies and equitable care pathways.

With coordinated policy leadership and evidence‑based planning, outcomes can improve dramatically. NCCPs act as the bridge between ambition and action – and it is time to ensure they fully reflect the urgency and opportunity of our collective response.

Share

Recent news

News

England’s lung cancer screening programme: lessons from a national roll-out

England’s lung cancer screening programme: lessons from a national roll-out

A new article in Nature Medicine presents findings from the first five years of the NHS screening programme for lung cancer in England, and the results are striking.

News

Reflections from LuCE’s inaugural conference

Reflections from LuCE’s inaugural conference

Last month, the Network attended the inaugural Lung Cancer Europe conference in Vienna, which focused on the power of co‑creation in advocacy.

Blog

Lung cancer: the looming economic crisis governments can’t ignore

Lung cancer: the looming economic crisis governments can’t ignore

Lung cancer carries a heavy cost – not only for the people diagnosed,  but for health systems and economies alike.

The Lung Cancer Policy Network
Cookie Settings

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.